MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 6, 2007, Pages 821-832

  Fung, Maggie K L ^a   Cheung, Hiu Wing ^a   Wong, Hing Lok ^a   Yuen, Hiu Fung ^a   Ling, Ming Tat ^a   Chan, Kowk Wah ^a   Wong, Yong Chuan ^a   Cheung, Annie L M ^a   Wang, Xianghong ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

MAD2; Mitotic checkpoint; Testicular germ cell tumour

Indexed keywords

DEMECOLCINE; NOCODAZOLE; PROTEIN MAD2;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GERM CELL TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE; MITOSIS; MITOSIS INDEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEMINOMA;

ADULT; AGED; AGED, 80 AND OVER; CALCIUM-BINDING PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CHROMOSOMAL INSTABILITY; CHROMOSOME SEGREGATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MITOSIS; NERVE TISSUE PROTEINS; REPRESSOR PROTEINS; SEMINOMA; TESTICULAR NEOPLASMS; TESTIS;

EID: 34249729514     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.03.014     Document Type: Article

References (55)

1. Jallepalli P.V., and Lengauer C. Chromosome segregation and cancer: cutting through the mystery. Nat. Rev. Cancer 1 (2001) 109-117
2. Wassmann K., and Benezra R. Mitotic checkpoints: from yeast to cancer. Curr. Opin. Genet. Dev. 11 (2001) 83-90
3. Draviam V.M., Xie S., and Sorger P.K. Chromosome segregation and genomic stability. Curr. Opin. Genet. Dev. 14 (2004) 120-125
4. Jefford C.E., and Irminger-Finger I. Mechanisms of chromosome instability in cancers. Crit. Rev. Oncol./Hematol. 59 (2006) 1-14
5. Li Y., and Benezra R. Identification of a human mitotic checkpoint gene: hsMAD2. Science 274 (1996) 246-248
6. Gorbsky G.J., Chen R.H., and Murray A.W. Microinjection of antibody to Mad2 protein into mammalian cells in mitosis induces premature anaphase. J. Cell Biol. 141 (1998) 1193-1205
7. Dobles M., Liberal V., Scott M.L., Benezra R., and Sorger P.K. Chromosome missegregation and apoptosis in mice lacking the mitotic checkpoint protein Mad2. Cell 101 (2000) 635-645
8. Michel L.S., Liberal V., Chatterjee A., Kirchwegger R., Pasche B., Gerald W., Dobles M., Sorger P.K., Murty V.V., and Benezra R. MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature 409 (2001) 355-359
9. Cahill D.P., Lengauer C., Yu J., Riggins G.J., Willson J.K., Markowitz S.D., Kinzler K.W., and Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature 392 (1998) 300-303
10. Takahashi T., Haruki N., Nomoto S., Masuda A., Saji S., Osada H., and Takahashi T. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers. Oncogene 18 (1999) 4295-4300
11. Wang X., Jin D.Y., Ng R.W., Feng H., Wong Y.C., Cheung A.L., and Tsao S.W. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Cancer Res. 62 (2002) 1662-1668
12. Mondal G., Sengupta S., Panda C.K., Gollin S.M., Saunders W.S., and Roychoudhury S. Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer. Carcinogenesis 28 (2006) 81-92
13. Wang X., Jin D.Y., Wong Y.C., Cheung A.L., Chun A.C., Lo A.K., Liu Y., and Tsao S.W. Correlation of defective mitotic checkpoint with aberrantly reduced expression of MAD2 protein in nasopharyngeal carcinoma cells. Carcinogenesis 21 (2000) 2293-2297
14. Sze K.M., Ching Y.P., Jin D.Y., and Ng I.O. Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells. J. Biomed. Sci. 11 (2004) 920-927
15. Kops G.J., Weaver B.A., and Cleveland D.W. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer 5 (2005) 773-785
16. Yoon D.S., Wersto R.P., Zhou W., Chrest F.J., Garrett E.S., Kwon T.K., and Gabrielson E. Variable levels of chromosomal instability and mitotic spindle checkpoint defects in breast cancer. Am. J. Pathol. 161 (2002) 391-397
17. Baek K.H., Shin H.J., Yoo J.K., Cho J.H., Choi Y.H., Sung Y.C., McKeon F., and Lee C.W. p53 deficiency and defective mitotic checkpoint in proliferating T lymphocytes increase chromosomal instability through aberrant exit from mitotic arrest. J. Leukoc. Biol. 73 (2003) 850-861
18. Hanks S., Coleman K., Reid S., Plaja A., Firth H., Fitzpatrick D., Kidd A., Mehes K., Nash R., Robin N., Shannon N., Tolmie J., Swansbury J., Irrthum A., Douglas J., and Rahman N. Constitutional aneuploidy and cancer predisposition caused by biallelic mutations in BUB1B. Nat. Genet. 36 (2004) 1159-1161
19. Yuan B., Xu Y., Woo J.H., Wang Y., Bae Y.K., Yoon D.S., Wersto R.P., Tully E., Wilsbach K., and Gabrielson E. Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin. Cancer Res. 12 (2006) 405-410
20. Jeong S.J., Shin H.J., Kim S.J., Ha G.H., Cho B.I., Baek K.H., Kim C.M., and Lee C.W. Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis. Cancer Res. 64 (2004) 8666-8673
21. Hernando E., Orlow I., Liberal V., Nohales G., Benezra R., and Cordon-Cardo C. Molecular analyses of the mitotic checkpoint components hsMAD2, hBUB1 and hBUB3 in human cancer. Int. J. Cancer 95 (2001) 223-227
22. Percy M.J., Myrie K.A., Neeley C.K., Azim J.N., Ethier S.P., and Petty E.M. Expression and mutational analyses of the human MAD2L1 gene in breast cancer cells. Genes Chromosomes Cancer 29 (2000) 356-362
23. Imai Y., Shiratori Y., Kato N., Inoue T., and Omata M. Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers. Jpn. J. Cancer Res. 90 (1999) 837-840
24. di Pietro A., Vries E.G., Gietema J.A., Spierings D.C., and de Jong S. Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours. Int. J. Biochem. Cell Biol. 37 (2005) 2437-2456
25. Mostofi F.K. Pathology of germ cell tumors of testis: a progress report. Cancer 45 (1980) 1735-1754
26. Skakkebaek N.E. Possible carcinoma-in-situ of the testis. Lancet 2 (1972) 516-517
27. von Eyben F.E. Chromosomes, genes, and development of testicular germ cell tumors. Cancer Genet. Cytogenet. 151 (2004) 93-138
28. Fung M.K., Cheung H.W., Ling M.T., Cheung A.L., Wong Y.C., and Wang X. Role of MEK/ERK pathway in the MAD2-mediated cisplatin sensitivity in testicular germ cell tumour cells. Br. J. Cancer 95 (2006) 475-484
29. Zhang S., Wu Y., Zeng Y., Zech L., and Klein G. Cytogenetic studies on an epithelioid cell line derived from nasopharyngeal carcinoma. Hereditas 97 (1982) 23-28
30. Tighe A., Johnson V.L., Albertella M., and Taylor S.S. Aneuploid colon cancer cells have a robust spindle checkpoint. EMBO Rep. 2 (2001) 609-614
31. Chresta C.M., Masters J.R., and Hickman J.A. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res. 56 (1996) 1834-1841
32. Spierings D.C., de Vries E.G., Stel A.J., te R.N., Vellenga E., and de J.S. Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis. Oncogene 23 (2004) 4862-4872
33. Chen R.H., Shevchenko A., Mann M., and Murray A.W. Spindle checkpoint protein Xmad1 recruits Xmad2 to unattached kinetochores. J. Cell. Biol. 143 (1998) 283-295
34. Musacchio A., and Hardwick K.G. The spindle checkpoint: structural insights into dynamic signalling. Nat. Rev., Mol. Cell Biol. 3 (2002) 731-741
35. Hardwick K.G., Johnston R.C., Smith D.L., and Murray A.W. MAD3 encodes a novel component of the spindle checkpoint which interacts with Bub3p,Cdc20p, and Mad2p. J. Cell Biol. 148 (2000) 871-882
36. Bharadwaj R., and Yu H. The spindle checkpoint, aneuploidy, and cancer. Oncogene 23 (2004) 2016-2027
37. Shah J.V., and Cleveland D.W. Waiting for anaphase: Mad2 and the spindle assembly checkpoint. Cell 103 (2000) 997-1000
38. Gorbsky G.J. The mitotic spindle checkpoint. Curr. Biol. 11 (2001) R1001-R1004
39. Yu H. Regulation of APC-Cdc20 by the spindle checkpoint. Curr. Opin. Cell Biol. 14 (2002) 706-714
40. Shin H.J., Baek K.H., Jeon A.H., Kim S.J., Jang K.L., Sung Y.C., Kim C.M., and Lee C.W. Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation. Oncogene 22 (2003) 3853-3858
41. Geley S., Kramer E., Gieffers C., Gannon J., Peters J.M., and Hunt T. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J. Cell Biol. 153 (2001) 137-148
42. Gorbsky G.J. Cell cycle checkpoints: arresting progress in mitosis. Bioessays 19 (1997) 193-197
43. Van Hooser A., Goodrich D.W., Allis C.D., Brinkley B.R., and Mancini M.A. Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation. J. Cell. Sci. 111 Pt. 23 (1998) 3497-3506
44. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284 (1980) 555-556
45. Blajeski A.L., Phan V.A., Kottke T.J., and Kaufmann S.H. G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells. J. Clin. Invest. 110 (2002) 91-99
46. Rao P.H., Houldsworth J., Palanisamy N., Murty V.V., Reuter V.E., Motzer R.J., Bosl G.J., and Chaganti R.S. Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors. Cancer Res. 58 (1998) 4260-4263
47. Wilson C., Yang J., Strefford J.C., Summersgill B., Young B.D., Shipley J., Oliver T., and Lu Y.J. Overexpression of genes on 16q associated with cisplatin resistance of testicular germ cell tumor cell lines. Genes Chromosomes Cancer 43 (2005) 211-216
48. Lengauer C., Kinzler K.W., and Vogelstein B. Genetic instabilities in human cancers. Nature 396 (1998) 643-649
49. Kasai T., Iwanaga Y., Iha H., and Jeang K.T. Prevalent loss of mitotic spindle checkpoint in adult T-cell leukemia confers resistance to microtubule inhibitors. J. Biol. Chem. 277 (2002) 5187-5193
50. Campbell M.S., Chan G.K., and Yen T.J. Mitotic checkpoint proteins HsMAD1 and HsMAD2 are associated with nuclear pore complexes in interphase. J. Cell. Sci. 114 (2001) 953-963
51. Tanaka K., Nishioka J., Kato K., Nakamura A., Mouri T., Miki C., Kusunoki M., and Nobori T. Mitotic checkpoint protein hsMAD2 as a marker predicting liver metastasis of human gastric cancers. Jpn. J. Cancer Res. 92 (2001) 952-958
52. Li G.Q., Li H., and Zhang H.F. Mad2 and p53 expression profiles in colorectal cancer and its clinical significance. World J. Gastroenterol. 9 (2003) 1972-1975
53. Li G.Q., and Zhang H.F. Mad2 and p27 expression profiles in colorectal cancer and its clinical significance. World J. Gastroenterol. 10 (2004) 3218-3220
54. Hernando E., Nahle Z., Juan G., Diaz-Rodriguez E., Alaminos M., Hemann M., Michel L., Mittal V., Gerald W., Benezra R., Lowe S.W., and Cordon-Cardo C. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature 430 (2004) 797-802
55. Cheung H.W., Jin D.Y., Ling M.T., Wong Y.C., Wang Q., Tsao S.W., and Wang X. Mitotic arrest deficient 2 expression induces chemosensitization to a DNA-damaging agent, cisplatin, in nasopharyngeal carcinoma cells. Cancer Res. 65 (2005) 1450-1458